1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : MAJOR PHARMACEUTICALS
  4. NEUROCRINE BIOSCIENCES, INC.
Neurocrine Biosciences, Inc. XNAS: NBIX
137.23 -0.12 (-0.09%)
598.5K
XNAS Volume

XNAS 14 Oct, 2025 5:30 PM (EDT)

Watchlist

Portfolio

Alert

Neurocrine Biosciences, Inc. - NBIX - stock price prediction, stock price target, analyst ratings from 26 analysts

Neurocrine Biosciences, Inc. has a share price target of US$ 169, revenue growth forecast of 18.8%, and profit growth estimate of 32.0% for FY25, based on top 26 analyst calls.